Jonathan A. Pachter,Jennifer E. Ring,David T. Weaver,Yan Wang
申请号：
US15738999
公开号：
US20180177788A1
申请日:
2016.06.29
申请国别(地区):
US
年份:
2018
代理人:
摘要：
This invention relates to methods comprising administering a FAK inhibitor and an immunotherapeutic agent such as anti-PD-1 or anti-PD-L1； that are useful in the treatment of abnormal cell growth, such as cancer, in mammals, especially humans.
